跳至主要内容
临床试验/JPRN-UMIN000014505
JPRN-UMIN000014505招募中未知

Efficacy of aflibercept for Macular edema secondary to central retinal vein occlusion (CRVO) - Investigation of Eylea for CRVO

Asahikawa Medical University0 个研究点目标入组 30 人开始时间: 2014年7月8日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) The following exclusions apply to the study eye only. Prior treatment with steroids (<3 months) History of vitrectomy surgery, submacular surgery, or other surgical intervention. 2) Active intraocular inflammation. 3) Hypersensitivity or allergy to fluorescein or indocyanine green, clinically significant drug allergy or known hypersensitivity to therapeutic or diagnostic protein products, or to any of the study drugs or their components. 4) pregnant women and nursing mothers. 5) Patient who the doctor in charge judges are ineligible for the study.

研究者

相似试验